IRTC News and Press, iRhythm Technologies Inc. From 03/04/24

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and help prevent disease, announced today that it intends to offer, subject to ma...

iRhythm is the first medical device company to join the Epic community, using Aura to drive efficiencies through EHR integration The collaboration will expand access to Zio service across the continuum of patient care—from cardiology to primary care to emergency departments and bey...

2024-02-22 20:58:11 ET iRhythm Technologies, Inc. (IRTC) Q4 2023 Earnings Conference Call February 22, 2024, 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - President and CEO Brice Bobzien - Chief Financial ...

2024-02-22 16:40:38 ET More on iRhythm Technologies iRhythm Technologies Q4 2023 Earnings Preview iRhythm Technologies expects FY24 revenue of about $575M to $585M Seeking Alpha’s Quant Rating on iRhythm Technologies Historical earnings data for iRhyth...

SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31,...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022, and May 30, 2023 a...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022 and May 30, 2023 an...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022 and May 30, 2023 an...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022, and May 30, 2023 a...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in iRhythm stock or options between January 11, 2022 and May 30, 2023 an...